RF24 | PSUN94 Long-Term Safety of Diazoxide Choline Extended-Release (DCCR) Tablets in Patients with Prader-Willi Syndrome

BACKGROUND: Prader-Willi syndrome (PWS), a rare genetic neurobehavioral-metabolic condition, is characterized by hyperphagia, accumulation of excess fat, hypotonia, and behavioral/psychological complications. There are no currently approved medications to treat hyperphagia in patients with PWS; DCCR...

Descripción completa

Detalles Bibliográficos
Autores principales: Woloschak, Michael, Miller, Jennifer, Felner, Eric, Bird, Lynne, Angulo, Moris, Mejia-Corletto, Jorge, Gevers, Evelien, Shoemaker, Ashley, Yanovski, Jack, Butler, Merlin, Salehi, Parisa, Stevenson, David, Wilding, John, Abuzzahab, Jennifer, Konczal, Laura, Guftar Shaikh, M, Viskochil, David, Lah, Melissa, Mathew, Verghese, Yen, Kristen, Bhatnagar, Anish, Obrynba, Kathryn
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Adipose Tissue, Appetite, & Obesity
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9624606/
http://dx.doi.org/10.1210/jendso/bvac150.074

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9624606/
http://dx.doi.org/10.1210/jendso/bvac150.074

Ejemplares similares